Clinical and Radiologic Improvement Following Tocilizumab Administration in Patients With SARS-CoV-2

We report on 2 severely ill patients with COVID-19 treated with tocilizumab within 7 to 10 days of onset of symptoms. Tocilizumab markedly improved their clinical condition and was associated with regression of abnormalities on chest computed tomography within 1 week of tocilizumab administration.
Source: Clinical Pulmonary Medicine - Category: Respiratory Medicine Tags: Images in Pulmonary Medicine Source Type: research